Loading…
Reported covered position: Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Client: NOVO NORDISK · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · fourth_quarter · Q4
Issues related to reimbursement under Medicare Part B generally Issues related to Medicare Part D, generally HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Value-based contracting and communications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · fourth_quarter · Q4
Source: Senate LDA
| NOVO NORDISK |
| 8 |
| 2018–2019 |
| SAMSUNG ELECTRONICS AMERICA, INC. | 8 | 2017–2019 |
| THE BOEING COMPANY | 8 | 2017–2019 |
| ASSURED GUARANTY MUNICIPAL CORP. | 7 | 2018–2019 |
| PFIZER, INC. | 7 | 2018–2019 |
| FIRST DATA CORPORATION | 3 | 2017 |
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Orange Book Transparency Act of 2020
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Orange Book Transparency Act of 2020
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Orange Book Transparency Act of 2020
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S.771)
Orange Book Transparency Act of 2020
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Further Extension of Continuing Appropriations Act, 2021
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Further Extension of Continuing Appropriations Act, 2021
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S.771)
Further Extension of Continuing Appropriations Act, 2021
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Further Extension of Continuing Appropriations Act, 2021
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Quadrennial Homeland Security Review Technical Corrections Act of 2019
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally -Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Structured Settlement Claimants Rights Act of 2019
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212)
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Preventative Health Savings Act (H.R. 2584/S. 1361)
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Preventative Health Savings Act (H.R. 2584/S. 1361)
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Preventative Health Savings Act (H.R. 2584/S. 1361)
Chronic Disease Management Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Chronic Disease Management Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Chronic Disease Management Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Strengthening Support For Veterans with Service Animals Act
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 4952, The Advancing Innovation and Reinvigorating Widespread Access to Viable Electromagnetic Spectrum (AIRWAVES Act). S. 3157, The STREAMLINE Small Cell Deployment Act. Outreach and monitoring relating technology issues, including 5G, affecting the telecommunications industry.
Stop Taxing Our Potential Act of 2019
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
Leave No Americans Behind Act of 2020
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
Help Extend Auditory Relief (HEAR) Act of 2020
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
Empower our Girls Act
Client: PERFORMANCE BASED BUILDING COALITION · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- H.R. 960, S. 236 - Public Building Renewal Act
Empower our Girls Act
Client: PERFORMANCE BASED BUILDING COALITION · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- H.R. 960, S. 236 - Public Building Renewal Act
Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 340/H.R. 965)
Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 340/H.R. 965)
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Preventative Health Savings Act (H.R. 2584/S. 1361)
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Preventative Health Savings Act (H.R. 2584/S. 1361)
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Preventative Health Savings Act (H.R. 2584/S. 1361)
Chronic Disease Management Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Chronic Disease Management Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Chronic Disease Management Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Special Counsel Transparency Act
Client: PERFORMANCE BASED BUILDING COALITION · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- H.R. 960, S. 236 - Public Building Renewal Act
Special Counsel Transparency Act
Client: PERFORMANCE BASED BUILDING COALITION · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- H.R. 960, S. 236 - Public Building Renewal Act
Stop the Spread of Invasive Mussels Act of 2019
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
Counterfeit Goods Seizure Act of 2019
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
SANTA Act
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 340/H.R. 965)
A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 340/H.R. 965)
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Treat and Reduce Obesity Act of 2019
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Consolidated Appropriations Act, 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally -Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Improving Access To Affordable Prescription Drugs Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S.771)
STREAMLINE Small Cell Deployment Act
Client: SAMSUNG ELECTRONICS AMERICA, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
H. R. 4952, The Advancing Innovation and Reinvigorating Widespread Access to Viable Electromagnetic Spectrum (AIRWAVES Act). S. 3157, The STREAMLINE Small Cell Deployment Act. Outreach and monitoring relating technology issues, including 5G, affecting the telecommunications industry.
Improving Access To Affordable Prescription Drugs Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S.771)
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212)
Affordable and Safe Prescription Drug Importation Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453). Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469); and the Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S. 771)
Affordable and Safe Prescription Drug Importation Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453). Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469); and the Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S. 771)
Affordable and Safe Prescription Drug Importation Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453) - Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program - Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) - Drug evaluation and review; compassionate use expanded access; Right to Try Act of 2017 (H.R. 878/S. 204); expedited pathways; innovation incentives; implementation of PDUFA IV and BSUFA II - Issues related to drug pricing and value, generally; Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Vaccines and infectious diseases; antimicrobials
Affordable and Safe Prescription Drug Importation Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453) - Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program - Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) - Drug evaluation and review; compassionate use expanded access; Right to Try Act of 2017 (H.R. 878/S. 204); expedited pathways; innovation incentives; implementation of PDUFA IV and BSUFA II - Issues related to drug pricing and value, generally; Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Vaccines and infectious diseases; antimicrobials
Affordable and Safe Prescription Drug Importation Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) Virtual Medicare Diabetes Prevention Program Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771)
Affordable and Safe Prescription Drug Importation Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) - Issues related to the FDA Reauthorization Act (Pub.L. 115-52) - Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771) - Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)
Affordable and Safe Prescription Drug Importation Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) - Issues related to the FDA Reauthorization Act (Pub.L. 115-52) - Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771) - Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)
Affordable and Safe Prescription Drug Importation Act
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to the importation of prescription medicines; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Antibiotic resistance; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization - Issues related to drug pricing and value, generally - Reimbursement for products treating Sickle Cell Disease
Affordable and Safe Prescription Drug Importation Act
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to the importation of prescription medicines; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Antibiotic resistance; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization - Issues related to drug pricing and value, generally
Affordable and Safe Prescription Drug Importation Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) Treat and Reduce Obesity Act (H.R. 1953/S. 830) Medicare Diabetes Prevention Program; diabetes self-management education Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625), including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff
Consolidated Appropriations Act, 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Consolidated Appropriations Act, 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251) Treat and Reduce Obesity Act (H.R. 1953/S. 830) Medicare Diabetes Prevention Program; diabetes self-management education; Preventing Diabetes in Medicare Act (H.R. 3124/S. 1299) Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625), including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff
Consolidated Appropriations Act, 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Consolidated Appropriations Act, 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Consolidated Appropriations Act, 2018
Client: ASTELLAS PHARMA US, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to Medicare Part B (HOPPS), generally - Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Consolidated Appropriations Act, 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) Treat and Reduce Obesity Act (H.R. 1953/S. 830) Medicare Diabetes Prevention Program; diabetes self-management education Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625), including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff
Consolidated Appropriations Act, 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Consolidated Appropriations Act, 2018
Client: ASTELLAS PHARMA US, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to Medicare Part B (HOPPS), generally - Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Consolidated Appropriations Act, 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Consolidated Appropriations Act, 2018
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to reimbursement under Medicare Part B generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
Consolidated Appropriations Act, 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Consolidated Appropriations Act, 2018
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to reimbursement under Medicare Part B generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
American Health Care Act of 2017
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Diabetes prevention, generally - Implementation of the Clinical Care Commission Act (Pub.L. 115-80) - World Hemophilia Day - Issues related to medication affordability and access, generally - American Health Care Act/Better Care Reconciliation Act (H.R. 1628)
American Health Care Act of 2017
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Chronic Disease Management Act (H.R. 4978/S. 2410) Diabetes prevention, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Growth Awareness Week 2018 Issues related to medication affordability and access, generally American Health Care Act/Better Care Reconciliation Act (H.R. 1628)
American Health Care Act of 2017
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Diabetes prevention, generally - Implementation of the Clinical Care Commission Act (Pub.L. 115-80) - World Hemophilia Day - Issues related to medication affordability and access, generally - American Health Care Act/Better Care Reconciliation Act (H.R. 1628) - Chronic Disease Management Act (H.R. 4978/S. 2410)
American Health Care Act of 2017
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251) Diabetes prevention, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) World Hemophilia Day Issues related to medication affordability and access, generally American Health Care Act/Better Care Reconciliation Act (H.R. 1628)
Improving Access To Affordable Prescription Drugs Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453). Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469); and the Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S. 771)
Improving Access To Affordable Prescription Drugs Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
National Diabetes Prevention Program and other CDC diabetes prevention activities in Pub.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations). Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771)
Improving Access To Affordable Prescription Drugs Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453). Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469); and the Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S. 771)
Improving Access To Affordable Prescription Drugs Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) Virtual Medicare Diabetes Prevention Program Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771)
Improving Access To Affordable Prescription Drugs Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
National Diabetes Prevention Program and other CDC diabetes prevention activities in Pub.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations). Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771)
Improving Access To Affordable Prescription Drugs Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) - Issues related to the FDA Reauthorization Act (Pub.L. 115-52) - Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771) - Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)
Improving Access To Affordable Prescription Drugs Act
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) - Issues related to the FDA Reauthorization Act (Pub.L. 115-52) - Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771) - Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)
Bipartisan Budget Act of 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Bipartisan Budget Act of 2018
Client: ASTELLAS PHARMA US, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to Medicare Part B (HOPPS), generally - Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Bipartisan Budget Act of 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) Treat and Reduce Obesity Act (H.R. 1953/S. 830) Medicare Diabetes Prevention Program; diabetes self-management education Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625), including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff
Bipartisan Budget Act of 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Bipartisan Budget Act of 2018
Client: ASTELLAS PHARMA US, INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to Medicare Part B (HOPPS), generally - Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Bipartisan Budget Act of 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Bipartisan Budget Act of 2018
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to reimbursement under Medicare Part B generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
Bipartisan Budget Act of 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
Bipartisan Budget Act of 2018
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Issues related to reimbursement under Medicare Part B generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
Bipartisan Budget Act of 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Bipartisan Budget Act of 2018
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251) Treat and Reduce Obesity Act (H.R. 1953/S. 830) Medicare Diabetes Prevention Program; diabetes self-management education; Preventing Diabetes in Medicare Act (H.R. 3124/S. 1299) Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625), including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff
Bipartisan Budget Act of 2018
Client: PFIZER INC. · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Treat and Reduce Obesity Act of 2017
Client: NOVO NORDISK · Firm: ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
House and Senate Appropriations for FY ending Sept. 30, 2019
Issues related to lobbying disclosure for US affiliates
HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Issues related to drug pricing and value, generally
Issues related to Medicare Part D, including non-interference, rebate policy issues Issues related to drug pricing, value, and transparency, generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · fourth_quarter · 4T
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Preventative Health Savings Act (H.R. 2584/S. 1361)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · third_quarter · Q3
Issues related to Medicare Part B, generally Issues related to Medicare Part D, including program restructuring, rebate reform, and beneficiary out-of-pocket costs Value-based payment arrangements
Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 340/H.R. 965)
Issues involving international trade, including IP protections
- Issues related to international tax reform
Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to biosimilars, generally Rebate reform, patient out-of-pocket costs, and value-based payment arrangements, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · third_quarter · Q3
Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
Preventative Health Savings Act (H.R. 2584/S. 1361)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · third_quarter · Q3
Vaccines and infectious diseases; antimicrobials
Biofuels, renewable chemicals/bio-based products
Issued relating to the 340B Drug Pricing Program Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; access to samples for testing; coding; naming; interchangeability and pharmacy substitution; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, generally
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · third_quarter · Q3
House and Senate Appropriations for FY ending Sept. 30, 2019
Issues related to lobbying disclosure for US affiliates
Issues related to Medicare Part D, including non-interference, rebate policy issues Issues related to drug pricing, value, and transparency, generally
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety - Tax
- Fuel economy, sustainability
- General global communications issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSURED GUARANTY MUNICIPAL CORP. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
- Legislative proposals impacting Puerto Rico, including the Bipartisan Budget Act of 2018
- Federal bankruptcy issues that affect Puerto Rico and/or impact the municipal bond market - Issues relating to the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) (Pub.L. 114-187)
- Issues relating to Puerto Rico's Medicaid program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
Issues involving international trade, including IP protections
Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 340/H.R. 965)
- Issues related to international tax reform
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
Funding for antimicrobial resistance programs Funding for renewable chemicals/bio-based products Funding for biodefense and emergency preparedness research, development and procurement, including reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA)
Biofuels, renewable chemicals/bio-based products
Genetically engineered (GE) animals
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · second_quarter · Q2
HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Issues related to drug pricing and value, generally
Issues related to Medicare Part D, including non-interference, rebate policy issues Issues related to drug pricing, value, and transparency, generally
Issues related to lobbying disclosure for US affiliates
PFIZER INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
- Issues involving international trade
- Issues related to international tax reform
-Issues related to Medicare Part B, generally -Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
CBO scoring of preventive health services, generally
Medicare Diabetes Prevention Program Treat and Reduce Obesity Act (H.R. 1530/S. 595) Issues related to Medicare Part D, generally; Part D Rebate Rule; 6 Protected Classes Issues related to International Price Indexing (IPI)/reference pricing in Medicare Part B CMS coverage of diabetes technologies/services Medicaid rebate cap, including H.R. 107
Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S.771)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
Issues related to reimbursement under Medicare Part B generally Issues related to Medicare Part D, generally HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Value-based contracting and communications
Genetically engineered (GE) animals
Funding for antimicrobial resistance programs Funding for renewable chemicals/bio-based products Funding for biodefense and emergency preparedness research, development and procurement, including reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA)
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
Issues related to Medicare Part D, generally
HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Issues related to drug pricing and value, generally Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) Issues related to the importation of prescription medicines, generally
House and Senate Appropriations for FY ending Sept. 30, 2019
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
- Issues related to reauthorization of the Export-Import Bank
- NASA reauthorization
- International agreements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
H. R. 4952, The Advancing Innovation and Reinvigorating Widespread Access to Viable Electromagnetic Spectrum (AIRWAVES Act). S. 3157, The STREAMLINE Small Cell Deployment Act. Outreach and monitoring relating technology issues, including 5G, affecting the telecommunications industry.
Outreach and monitoring related to bilateral and multilateral trade policy and proceedings.
Issues related to STEM education and workforce development.
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
- Fuel economy, sustainability
- General global communications issues
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety - Tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSURED GUARANTY MUNICIPAL CORP. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2019 · first_quarter · Q1
- Issues relating to Puerto Rico's Medicaid program
- Legislative proposals impacting Puerto Rico, including the Bipartisan Budget Act of 2018
- Federal bankruptcy issues that affect Puerto Rico and/or impact the municipal bond market - Issues relating to the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) (Pub.L. 114-187)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
- Issues related to reauthorization of the Export-Import Bank
- NASA reauthorization
- International agreements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
H. R. 4952, The Advancing Innovation and Reinvigorating Widespread Access to Viable Electromagnetic Spectrum (AIRWAVES Act). S. 3157, The STREAMLINE Small Cell Deployment Act. Outreach and monitoring relating technology issues, including 5G, affecting the telecommunications industry.
Issues related to consumer protection, cybersecurity and the Internet of Things.
Outreach and monitoring related to bilateral and multilateral trade policy and proceedings.
PFIZER INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
- Issues related to international tax reform
Issues related to the importation of prescription medicines, generally Antibiotic resistance; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Reimbursement for products treating Sickle Cell Disease
- Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212)
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
- General global communications issues
- Fuel economy, sustainability
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety - Tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSURED GUARANTY MUNICIPAL CORP. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
- Issues relating to Puerto Rico's Medicaid program
- Federal bankruptcy issues that affect Puerto Rico and/or impact the municipal bond market - Issues relating to the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) (Pub.L. 114-187)
- Legislative proposals impacting Puerto Rico, including the Bipartisan Budget Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) Virtual Medicare Diabetes Prevention Program Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771)
Chronic Disease Management Act (H.R. 4978/S. 2410) Diabetes prevention, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Growth Awareness Week 2018 Issues related to medication affordability and access, generally American Health Care Act/Better Care Reconciliation Act (H.R. 1628)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
Vaccines and infectious diseases; antimicrobials
Funding for Antimicrobial Resistance Programs Funding for biofuels; Farm Bill Reauthorization Funding for Biodefense and Emergency Preparedness Research, Development and Procurement, including reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA) (S. 2852/H.R. 6378)
Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453). Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469); and the Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S. 771)
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · fourth_quarter · Q4
HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the Bayh-Dole Act (Pub. L. 96-517) Issues related to drug pricing and value, generally Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) (S. 2852/H.R. 6378) Issues related to the importation of prescription medicines, generally
Issues related to Medicare Part D
"Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)"
PFIZER INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
Issues related to the importation of prescription medicines, generally Antibiotic resistance; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Reimbursement for products treating Sickle Cell Disease
- Issues involving international trade
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
Preventative Health Savings Act (H.R. 2953/S. 216); CBO scoring of preventive health, generally
Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251) Diabetes prevention, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) World Hemophilia Day Issues related to medication affordability and access, generally American Health Care Act/Better Care Reconciliation Act (H.R. 1628)
National Diabetes Prevention Program and other CDC diabetes prevention activities in Pub.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations). Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
Issues related to reimbursement under Medicare Part B generally Issues related to Medicare Part D, generally Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
Genetically engineered (GE) animals
Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453). Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469); and the Improving Access to Affordable Prescription Drugs Act (H.R. 1776/S. 771)
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the Bayh-Dole Act (Pub. L. 96-517) Issues related to drug pricing and value, generally Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) (S. 2852/H.R. 6378) Issues related to the importation of prescription medicines, generally
Issues related to Medicare Part D
"Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)"
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSURED GUARANTY MUNICIPAL CORP. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
- Legislative proposals impacting Puerto Rico, including the Bipartisan Budget Act of 2018
- Federal bankruptcy issues that affect Puerto Rico and/or impact the municipal bond market - Issues relating to the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) (Pub.L. 114-187)
- Issues relating to Puerto Rico's Medicaid program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
Issues related to STEM education and workforce development.
H. R. 4952, The Advancing Innovation and Reinvigorating Widespread Access to Viable Electromagnetic Spectrum (AIRWAVES Act). S. 3157, The STREAMLINE Small Cell Deployment Act. Outreach and monitoring relating technology issues, including 5G, affecting the telecommunications industry.
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
- NASA reauthorization
- Issues related to reauthorization of the Export-Import Bank
- International agreements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety - Tax
- Fuel economy, sustainability
- General global communications issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · third_quarter · Q3
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · 2A
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Issues related to reauthorization of the Export-Import Bank
- NASA reauthorization
- International agreements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Energy efficiency
- General issues involving trade
- Consumer protection - Cybersecurity - Internet of things
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Fuel economy, sustainability
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety - Tax
- General global communications issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSURED GUARANTY MUNICIPAL CORP. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Federal bankruptcy issues that affect Puerto Rico and/or impact the municipal bond market - Issues relating to the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) (Pub.L. 114-187)
- Legislative proposals impacting Puerto Rico, including the Bipartisan Budget Act of 2018
- Issues relating to Puerto Rico's Medicaid program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
- Issues related to the importation of prescription medicines; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Antibiotic resistance; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization - Issues related to drug pricing and value, generally - Reimbursement for products treating Sickle Cell Disease
- Issues related to international tax reform
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Diabetes prevention, generally - Implementation of the Clinical Care Commission Act (Pub.L. 115-80) - World Hemophilia Day - Issues related to medication affordability and access, generally - American Health Care Act/Better Care Reconciliation Act (H.R. 1628) - Chronic Disease Management Act (H.R. 4978/S. 2410)
- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453) - Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program - Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) - Drug evaluation and review; compassionate use expanded access; Right to Try Act of 2017 (H.R. 878/S. 204); expedited pathways; innovation incentives; implementation of PDUFA IV and BSUFA II - Issues related to drug pricing and value, generally; Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Vaccines and infectious diseases; antimicrobials
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · second_quarter · Q2
- Issues related to the Bayh-Dole Act (Pub. L. 96-517) - Issues related to drug pricing and value, generally - Issues related to the importation of prescription medicines, generally
- Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)
- Issues related to Medicare Part B (HOPPS), generally - Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- Issued relating to the 340B Drug Pricing Program, including the 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act (H.R. 4710); the Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act (S. 2312); and the Ensuring the Value of the 340B Program Act (S. 2453) - Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program - Issues related to biosimilars, generally; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212) - Drug evaluation and review; compassionate use expanded access; Right to Try Act of 2017 (H.R. 878/S. 204); expedited pathways; innovation incentives; implementation of PDUFA IV and BSUFA II - Issues related to drug pricing and value, generally; Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Vaccines and infectious diseases; antimicrobials
NOVO NORDISK via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- Diabetes prevention, generally - Implementation of the Clinical Care Commission Act (Pub.L. 115-80) - World Hemophilia Day - Issues related to medication affordability and access, generally - American Health Care Act/Better Care Reconciliation Act (H.R. 1628)
- Preventative Health Savings Act (H.R. 2953/S. 216); CBO scoring of preventive health, generally - National Diabetes Prevention Program and other CDC diabetes prevention activities in Pub.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations)
- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
PFIZER INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- Issues related to the importation of prescription medicines; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Antibiotic resistance; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization - Issues related to drug pricing and value, generally
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
- Issues involving international trade
ASTELLAS PHARMA US, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)
- Issues related to the Bayh-Dole Act (Pub. L. 96-517) - Issues related to drug pricing and value, generally - Issues related to the importation of prescription medicines, generally
- Issues related to Medicare Part B (HOPPS), generally - Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625) - Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)
ASSURED GUARANTY MUNICIPAL CORP. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- Legislative proposals impacting Puerto Rico, including the Bipartisan Budget Act of 2018
- Issues relating to Puerto Rico's Medicaid program
- Federal bankruptcy issues that affect Puerto Rico and/or impact the municipal bond market - Issues relating to the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA) (Pub.L. 114-187)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- General global communications issues
- Fuel economy, sustainability
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety - Tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- International agreements
- Issues related to reauthorization of the Export-Import Bank
- NASA reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making - Issues related to merger matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · Q1
- Consumer protection - Cybersecurity - Internet of things
- General issues involving trade
- General issues in the consumer electronics industry
ASSURED GUARANTY MUNICIPAL CORP. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2018 · first_quarter · RR
FIN - Legislative proposals that would amend federal bankruptcy code with respect to Puerto Rico or otherwise impact the municipal bond market. MMM - Legislative proposals impacting Medicaid, specifically those affecting Puerto Rico. BUD - Legislative proposals impacting Puerto Rico.
FIN - Legislative proposals that would amend federal bankruptcy code with respect to Puerto Rico or otherwise impact the municipal bond market. MMM - Legislative proposals impacting Medicaid, specifically those affecting Puerto Rico. BUD - Legislative proposals impacting Puerto Rico.
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · fourth_quarter · Q4
- Energy efficiency
- Consumer protection - Cybersecurity - Internet of things
- General issues in the computer industry
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · fourth_quarter · Q4
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
- Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · fourth_quarter · Q4
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · fourth_quarter · Q4
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety - Tax
- Fuel economy, sustainability
- General global communications issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST DATA CORPORATION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · fourth_quarter · 4T
- General issues with technology/cybersecurity
- General issues with banking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · fourth_quarter · Q4
- International agreements
- NASA reauthorization
- Issues related to reauthorization of the Export-Import Bank
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · fourth_quarter · Q4
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making - Issues related to merger matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST DATA CORPORATION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · Q3
- General issues with banking
- General issues with technology/cybersecurity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST DATA CORPORATION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · RR
General issues with banking and technology/cybersecurity.
General issues with banking and technology/cybersecurity.
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · Q3
Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · Q3
- General issues involving trade
- Energy efficiency
- General issues in the computer industry
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · Q3
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · Q3
- General global communications issues
- Fuel economy, sustainability
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues - Safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · Q3
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making - Issues related to merger matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · Q3
- International agreements
- Issues related to reauthorization of the Export-Import Bank
- NASA reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORD STREAM 2 AG via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · third_quarter · RR
Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
Issues related to the U.S. position toward the Nord Stream 2 pipeline, including potential financial sanctions affecting the project.
SAMSUNG ELECTRONICS AMERICA, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · second_quarter · Q2
- General issues in the computer industry
- Consumer protection - Cybersecurity - Internet of things
- General issues involving trade
PERFORMANCE BASED BUILDING COALITION via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · second_quarter · Q2
- H.R. 960, S. 236 - Public Building Renewal Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS, LLC via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · second_quarter · Q2
- General global communications issues
- General automotive industry issues - Issues relating to autonomous vehicles, education and communication - Cyber security issues
- Fuel economy, sustainability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · second_quarter · Q2
- International agreements
- Issues related to reauthorization of the Export-Import Bank
- NASA reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. via ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
2017 · second_quarter · Q2
- FCC Wireless Spectrum Rules - Issues related to Handset Exclusivity - Issues related to Universal Services Fund Reform - Issues related to Text Messaging and Pricing - Issues related to Special Access - Issues related to Cyber security - Broadband mapping legislation - Net neutrality rule making - Issues related to merger matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Genetically engineered (GE) animals
Issues related to reimbursement under Medicare Part B generally Issues related to Medicare Part D, generally HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Value-based contracting and communications
Funding for antimicrobial resistance programs Funding for renewable chemicals/bio-based products Funding for biodefense and emergency preparedness research, development and procurement, including reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Issues related to drug pricing and value, generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to biosimilars, generally Rebate reform, patient out-of-pocket costs, and value-based payment arrangements, generally.
Issues related to Medicare Part B, generally Issues related to Medicare Part D, including program restructuring, rebate reform, and beneficiary out-of-pocket costs Value-based payment arrangements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Chronic Disease Management Act (S. 1948/H.R. 3709) and issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Preventative Health Savings Act (H.R. 2584/S. 1361)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issued relating to the 340B Drug Pricing Program Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; access to samples for testing; coding; naming; interchangeability and pharmacy substitution; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, generally
Vaccines and infectious diseases; antimicrobials
Issues related to reimbursement under Medicare Part B generally Issues related to Medicare Part D, generally HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Value-based contracting and communications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
House and Senate Appropriations for FY ending Sept. 30, 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212)
Issues related to the importation of prescription medicines, generally Antibiotic resistance; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Reimbursement for products treating Sickle Cell Disease
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
Diabetes prevention, generally Issues related to medication affordability and access, generally Implementation of the Clinical Care Commission Act (Pub.L. 115-80) Issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Vaccines and infectious diseases; antimicrobials
Biofuels, renewable chemicals/bio-based products
Issued relating to the 340B Drug Pricing Program Biodefense research, development and procurement issues; Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; pandemic flu; MCM priority review voucher program Issues related to biosimilars, generally; access to samples for testing; coding; naming; interchangeability and pharmacy substitution; Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act Issues related to drug pricing and value, generally, including the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to the importation of prescription medicines, generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to lobbying disclosure for US affiliates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
Issues related to consumer protection, cybersecurity and the Internet of Things.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. R. 5515, S. 2987, S. 3073, H.R. 6147, H.R. 5895, S. 2975: Outreach and monitoring related to appropriations legislation including for federal procurement and energy efficiency programs.
Issues related to STEM education and workforce development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Issues involving international trade
-Issues related to Medicare Part B, generally - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
National Diabetes Prevention Program and other CDC diabetes prevention activities in Pub.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations). Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) Issues related to the FDA Reauthorization Act (Pub.L. 115-52) Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771)
Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251) Treat and Reduce Obesity Act (H.R. 1953/S. 830) Medicare Diabetes Prevention Program; diabetes self-management education; Preventing Diabetes in Medicare Act (H.R. 3124/S. 1299) Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625), including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff
Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Genetically engineered (GE) animals
Biofuels, renewable chemicals/bio-based products
Issues related to reimbursement under Medicare Part B generally Issues related to Medicare Part D, generally Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212)
- Issues related to international tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Chronic Disease Management Act (H.R. 4978/S. 2410)
Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) Treat and Reduce Obesity Act (H.R. 1953/S. 830) Medicare Diabetes Prevention Program; diabetes self-management education Issues related to Medicare Part D included in the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625), including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for Antimicrobial Resistance Programs Funding for biofuels; Farm Bill Reauthorization Funding for Biodefense and Emergency Preparedness Research, Development and Procurement, including reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA) (S. 2852/H.R. 6378)
Vaccines and infectious diseases; antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Outreach and monitoring related to bilateral and multilateral trade policy and proceedings.
Issues related to consumer protection, cybersecurity and the Internet of Things.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- General issues in the consumer electronics industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Issues involving international trade
- Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
- Preventative Health Savings Act (H.R. 2953/S. 216); CBO scoring of preventive health, generally - National Diabetes Prevention Program and other CDC diabetes prevention activities in Pub.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations)
- Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) - Issues related to the FDA Reauthorization Act (Pub.L. 115-52) - Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771) - Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Biofuels, renewable chemicals/bio-based products
- Issues related to reimbursement under Medicare Part B generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
- Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act of 2018; amendment on GE Salmon Labeling
- Funding for Antimicrobial Resistance Programs - Funding for biofuels; Farm Bill Reauthorization - Funding for Biodefense and Emergency Preparedness Research, Development and Procurement, including reauthorization of the Pandemic All-Hazards Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Issues related to reimbursement under Medicare Part B generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Issues related to Medicare Part D, generally; Bipartisan Budget Act (H.R. 1892); Consolidated Appropriations Act (H.R. 1625) - Medicaid; drug benefit design; pricing and rebates; and Section 1115 waivers
- Biofuels, renewable chemicals/bio-based products
- Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act of 2018; amendment on GE Salmon Labeling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
- Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710) - Issues related to the FDA Reauthorization Act (Pub.L. 115-52) - Improving Access To Affordable Prescription Drugs Act (H.R. 1776/S.771) - Drug importation, generally; Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Issues related to international tax reform
- Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R. 2212)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Energy efficiency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIN - Legislative proposals that would amend federal bankruptcy code with respect to Puerto Rico or otherwise impact the municipal bond market. MMM - Legislative proposals impacting Medicaid, specifically those affecting Puerto Rico. BUD - Legislative proposals impacting Puerto Rico.
- General issues involving trade
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- Consumer protection - Cybersecurity - Internet of things
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- energy star program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE